Evaluation of nitazoxanide in combination with pegylated interferon and ribavirin in treatment of patients with chronic HCV genotype 4 /
Mahmoud Mohammad Magdy Taha
Evaluation of nitazoxanide in combination with pegylated interferon and ribavirin in treatment of patients with chronic HCV genotype 4 / تقييم عقار النيتازوكسانيد فى علاج المرضى المصابين بالتهاب الكبد الفيروسى ج المزمن الطور الجينى الرابع مع الإنترفيرون والريبافيرين Mahmoud Mohammad Magdy Taha ; Supervised Gamal Eldeen Esmat Gameel , Maissa Elsaid Elraziky , Badawy Elkholy - Cairo : Mahmoud Mohammad Magdy Taha , 2012 - 76P. : charts , facsimiles ; 25cm
Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Tropical Medicine
Sustained virologic response (SVR ) rates of 50 % - 60 % have been achieved in patients with chronic hepatitis C (CHC) genotype 4 treated with peginterferon (PEG-IFN) plus ribavirin (RBV) . The safety and efficacy of nitazoxanide (NTZ) plus peginterferon alfa-2a , with ribavirin , were evaluated in a case controlled study at 2 centers in Egypt . This study aims at assessing the safety and efficacy of NTZ in treating Egyptian patients with CHC in combination with PEG-IFN and RBV
Chronic HCV Nitazoxanide Triple Therapy
Evaluation of nitazoxanide in combination with pegylated interferon and ribavirin in treatment of patients with chronic HCV genotype 4 / تقييم عقار النيتازوكسانيد فى علاج المرضى المصابين بالتهاب الكبد الفيروسى ج المزمن الطور الجينى الرابع مع الإنترفيرون والريبافيرين Mahmoud Mohammad Magdy Taha ; Supervised Gamal Eldeen Esmat Gameel , Maissa Elsaid Elraziky , Badawy Elkholy - Cairo : Mahmoud Mohammad Magdy Taha , 2012 - 76P. : charts , facsimiles ; 25cm
Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Tropical Medicine
Sustained virologic response (SVR ) rates of 50 % - 60 % have been achieved in patients with chronic hepatitis C (CHC) genotype 4 treated with peginterferon (PEG-IFN) plus ribavirin (RBV) . The safety and efficacy of nitazoxanide (NTZ) plus peginterferon alfa-2a , with ribavirin , were evaluated in a case controlled study at 2 centers in Egypt . This study aims at assessing the safety and efficacy of NTZ in treating Egyptian patients with CHC in combination with PEG-IFN and RBV
Chronic HCV Nitazoxanide Triple Therapy